|
CN109112126B
(zh)
*
|
2010-06-23 |
2024-06-14 |
库尔纳公司 |
通过抑制电压门控钠通道α亚基(SCNA)的天然反义转录物而治疗SCNA相关疾病
|
|
CA2804593C
(en)
|
2010-07-09 |
2015-11-24 |
Pfizer Limited |
Biphenyloxybenzensulphonamide derivatives useful as sodium channel inhibitors
|
|
JP2013531030A
(ja)
|
2010-07-12 |
2013-08-01 |
ファイザー・リミテッド |
電位開口型ナトリウムチャネルの阻害剤としてのｎ−スルホニルベンズアミド
|
|
CA2804351A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Chemical compounds
|
|
JP2013532184A
(ja)
*
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
電位開口型ナトリウムチャネル阻害剤として有用なｎ−スルホニルベンズアミド誘導体
|
|
JP2013536165A
(ja)
|
2010-07-12 |
2013-09-19 |
ファイザー・リミテッド |
痛みの処置のためのｎａｖ１．７阻害薬としてのスルホンアミド誘導体
|
|
JP2013532185A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
|
EP2655330B1
(en)
*
|
2010-12-22 |
2016-02-10 |
Purdue Pharma LP |
Substituted pyridines as sodium channel blockers
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
KR20150087400A
(ko)
|
2012-11-20 |
2015-07-29 |
버텍스 파마슈티칼스 인코포레이티드 |
인돌아민 2,3-디옥시게나제의 억제제로서 유용한 화합물
|
|
RU2683788C2
(ru)
|
2013-01-31 |
2019-04-02 |
Вертекс Фармасьютикалз Инкорпорейтед |
Амиды хинолина и хиназолина, полезные в качестве модуляторов натриевых каналов
|
|
RS56015B1
(sr)
|
2013-01-31 |
2017-09-29 |
Vertex Pharma |
Piridon amidi kao modulatori natrijumovih kanala
|
|
CA2898653C
(en)
*
|
2013-01-31 |
2021-09-28 |
Vertex Pharmaceuticals Incorporated |
Amides as modulators of sodium channels
|
|
UA119147C2
(uk)
*
|
2013-07-19 |
2019-05-10 |
Вертекс Фармасьютікалз Інкорпорейтед |
Сульфонаміди як модулятори натрієвих каналів
|
|
CA2931550C
(en)
*
|
2013-12-13 |
2023-09-26 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
EP3134729A1
(en)
|
2014-04-22 |
2017-03-01 |
Q-State Biosciences, Inc. |
Analysis of compounds for pain and sensory disorders
|
|
US10048275B2
(en)
|
2015-03-13 |
2018-08-14 |
Q-State Biosciences, Inc. |
Cardiotoxicity screening methods
|
|
EP3298448B1
(en)
|
2015-05-21 |
2024-09-04 |
President and Fellows of Harvard College |
Optogenetics microscope
|
|
NZ742038A
(en)
|
2015-10-07 |
2019-08-30 |
Univ Arizona |
Crmp2 sumoylation inhibitors and uses thereof
|
|
CA3030551C
(en)
*
|
2016-07-07 |
2025-05-06 |
Corteva Agriscience Llc |
PROCESSES FOR PREPARATION OF 4-ALCOXY-3-(ACYL OR ALKYL)OXYPICOLINAMIDES
|
|
EP3625214B1
(en)
|
2017-05-16 |
2022-07-06 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
|
AU2018300150A1
(en)
|
2017-07-11 |
2020-01-30 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US11529337B2
(en)
|
2018-02-12 |
2022-12-20 |
Vertex Pharmaceuticals Incorporated |
Method of treating pain
|
|
AU2019302534B2
(en)
|
2018-07-09 |
2024-10-03 |
Lieber Institute, Inc. |
Pyridazine compounds for inhibiting NaV1.8
|
|
CA3105657A1
(en)
|
2018-07-09 |
2020-01-16 |
Lieber Institute, Inc. |
Pyridine carboxamide compounds for inhibiting nav1.8
|
|
CN110885328B
(zh)
*
|
2018-09-10 |
2022-08-12 |
成都康弘药业集团股份有限公司 |
作为钠通道阻滞剂的磺酰胺类化合物及其用途
|
|
US12344595B2
(en)
|
2018-11-02 |
2025-07-01 |
Merck Sharp & Dohme Llc |
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors
|
|
JP7288051B2
(ja)
|
2018-11-02 |
2023-06-06 |
メルク・シャープ・アンド・ドーム・エルエルシー |
Ｎａｖ１．８阻害薬としての２－アミノ－Ｎ－ヘテロアリール－ニコチンアミド類
|
|
WO2020146682A1
(en)
*
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US12440481B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
CN112390745B
(zh)
*
|
2019-08-19 |
2022-10-21 |
江苏恒瑞医药股份有限公司 |
吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
|
|
BR112022004495A8
(pt)
*
|
2019-09-12 |
2023-04-18 |
Jiangxi Jemincare Group Co Ltd |
Compostos oxinitreto de piridina, composição farmacêutica compreendendo os mesmos e usos dos mesmos
|
|
BR112022010924A2
(pt)
|
2019-12-06 |
2022-09-06 |
Vertex Pharma |
Tetra-hidrofuranos substituídos como moduladores de canais de sódio
|
|
CN113045487B
(zh)
*
|
2019-12-27 |
2025-01-17 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
US11802122B2
(en)
|
2020-06-17 |
2023-10-31 |
Merck Sharp & Dohme Llc |
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors
|
|
US12516046B2
(en)
|
2020-06-17 |
2026-01-06 |
Merck Sharp & Dohme Llc |
2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
|
|
GEP20257795B
(en)
|
2021-05-07 |
2025-09-25 |
Merck Sharp & Dohme Llc |
Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors
|
|
SMT202500481T1
(it)
|
2021-06-04 |
2026-01-12 |
Vertex Pharma |
N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio
|
|
TW202317520A
(zh)
|
2021-06-15 |
2023-05-01 |
德商歌林達有限公司 |
經取代之吡唑醯胺
|
|
WO2023205463A1
(en)
|
2022-04-22 |
2023-10-26 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl compounds for the treatment of pain
|
|
EP4570788A1
(en)
|
2022-08-12 |
2025-06-18 |
Guangzhou Fermion Technology Co., Ltd. |
Compound as voltage-gated sodium channel inhibitor
|
|
EP4385979A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Multicyclic inhibitors of nav1.8
|
|
EP4385984A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Pyridine-n-oxides as inhibitors of nav1.8
|
|
AR131345A1
(es)
|
2022-12-14 |
2025-03-12 |
Gruenenthal Gmbh |
SULFOXIMINAS COMO INHIBIDORES DE NaV1.8
|
|
EP4385980A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Indazoles as inhibitors of nav1.8
|
|
CN118324743A
(zh)
*
|
2023-04-19 |
2024-07-12 |
中国科学院上海药物研究所 |
Nav1.8抑制剂及其制备方法和用途
|